-
Innovation Ranking
NewInnovation Ranking – Bio-Rad Laboratories Inc
Bio-Rad Laboratories Inc (Bio-Rad) develops, manufactures and markets a range of products and systems for life science research, healthcare, analytical chemistry and other markets. The company’s major products include reagents, apparatus, laboratory instruments, test systems, informatics systems, test kits and specialized quality controls. Bio-Rad offers its products to universities and medical schools, industrial research organizations, pharmaceutical manufacturers, government agencies, biotechnology researchers, food producers, food testing laboratories, reference laboratories, hospital and transfusion laboratories and physician office laboratories. It markets products through...
-
Sector Analysis
NewImmunochemistry Analyzers Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033
Immunochemistry Analyzers Market Report Overview The immunochemistry analyzers market size was valued at $1.41 billion in 2023 and is expected to grow at a CAGR of more than 4% during 2023-2033. Immunochemistry analyzers are analytical laboratory equipment used to perform tests for infectious diagnostics, specific proteins, and therapeutic drugs. They are typically offered in modular increments, which can operate independently or simultaneously as a unit. Immunochemistry Analyzers Market Outlook, 2023-2033 ($ Billion) Buy the Full Report for More Insights into...
-
Sector Analysis
NewPCR Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033
PCR Systems Market Report Overview The PCR Systems market size was $700.3 million in 2023. The market is expected to grow at a CAGR of more than 5% during 2023-2033. Polymerase Chain Reaction (PCR) systems are used to perform nucleic acid amplification, typically in support of investigations concerning the diagnosis or prognosis of cancer or infectious disease. PCR Systems Market Outlook, 2023-2033 ($ Million) Buy the Full Report for More Insights into the PCR Systems Market Forecast Download a Free...
-
Company Insights
Innovation and Patenting activity of Bio-Rad Laboratories Inc Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Bio-Rad Laboratories Inc Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – RAD-140 in Metastatic Breast Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - RAD-140 in Metastatic Breast Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.RAD-140 in Metastatic Breast Cancer Drug Details:RAD-140 is under development for the...
-
Sector Analysis
Chlamydia Trachomatis and Neisseria Gonorrhoeae Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
Chlamydia Trachomatis and Neisseria Gonorrhoeae Tests Market Report Overview The Chlamydia Trachomatis and Neisseria Gonorrhoeae Tests market size was $2.81 billion in 2023. The market will grow at a CAGR of less than 1% during 2023-2033. Chlamydia is a common sexually transmissible disease, caused by the bacteria Chlamydia Trachomatis. In women, Chlamydia Trachomatis infections are often asymptomatic. However, if left untreated they can cause pelvic inflammatory disease (PID), which, in turn, can lead to additional complications such as infertility, ectopic...
-
Analyst Opinions
Net Zero by 2050 – Industrial Decarbonization Gains Momentum (Vol.2)
Net Zero by 2050 Overview Businesses and tech giants globally are focusing on low-carbon products, renewables, and EVs to achieve net zero emissions. Key sectors such as aerospace, automotive, and technology are advancing sustainability through innovations in hydrogen, EVs, fuel cells, and smart energy solutions among others. The “Net Zero by 2050” report outlines decarbonization-related deals value and volume trends, VC investment activity and geographic trends, and leading investors. The report also provides facts and figures related to climate change,...
-
Sector Analysis
Human Immunodeficiency Virus (HIV) Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
Human Immunodeficiency Virus (HIV) Tests Market Report Overview The human immunodeficiency virus (HIV) tests market size was valued at $1.95 billion in 2023. The HIV test market will grow at a CAGR of more than 2% from 2023 to 2033. The Human Immunodeficiency Virus (HIV) has become one of the world’s most serious health issues affecting approximately 36.3 million people. In the first few weeks after attaining HIV, patients develop symptoms like fever, rash, sore throat, etc but as the...
-
Sector Analysis
Hepatitis B Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
Hepatitis B tests Market Report Overview The hepatitis B tests market size was valued at $1.75 billion in 2023. The hepatitis B tests market will grow at a CAGR of more than 2% from 2023 to 2033. Hepatitis B is a viral infection caused by the Hepatitis B virus (HBV). The virus attacks the liver and can cause acute and chronic disease, which might lead to liver failure, liver cancer or liver cirrhosis, kidney disease, and/or inflammation of blood vessels....
-
Macroeconomic Analysis
Israel PESTLE Insights – A Macroeconomic Outlook Report
Transport, storage and communication activities contributed 15.6% to Israel’s gross value added (GVA) in 2022, followed by mining, manufacturing and utilities activities (13.8%), and wholesale, retail and hotels activities (10.8%). In nominal terms, the three sectors are forecast to grow by 7.0%, 7.2%, and 6.9%, respectively, in 2023. Tel Aviv and Jerusalem accounted for 58.8% of the country’s GDP and 59.4% of Israel’s population in 2022, according to GlobalData.